Guide
Biosimilars pipeline report: A guide for understanding the growing market
To date, there have been 59 approvals and 41 launches in the U.S.
biosimilars market.
Biosimilars are a
promising product category, one that can provide patients
and doctors with more affordable treatment options. As
this market matures, its pipeline continues to grow. This
reference guide is a useful tool to visualize and understand
the current product landscape and potential future of this
emerging market.
